Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
SK Biopharmaceuticals.
(326030.KQ) Q3 2024
Earnings
326030.KQ
Aug 8
Confirmed
Aug 2022
Q4 2023
Q2 2024
Q3 2024
-580
-283
14
311
Details
Expected EPS
106
Actual EPS
311
Surprise EPS
205
Surprise Percent
+192.44%
Description
SK Biopharmaceuticals. (326030.KQ) has reported earnings of 311 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login